Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
about
Mild cognitive impairment: pathology and mechanisms.Cholinergic imaging in dementia spectrum disordersCortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.The neuropathology of probable Alzheimer disease and mild cognitive impairment.Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.The effects of aging vs. α7 nAChR subunit deficiency on the mouse brain transcriptome: aging beats the deficiency.Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment.Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairmentPre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's diseaseNeurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Finances in the older patient with cognitive impairment: "He didn't want me to take over".Current therapeutic targets for the treatment of Alzheimer's disease.The neuropathological profile of mild cognitive impairment (MCI): a systematic review.Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?Differentially disrupted functional connectivity of the subregions of the inferior parietal lobule in Alzheimer's disease.Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.Functional integrity of thalamocortical circuits differentiates normal aging from mild cognitive impairment.Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets.Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.
P2860
Q24631255-58328F24-A1E4-41EF-8C82-B6273F72EFC8Q26764933-8C466122-E916-42FB-91F9-9649CCF02CDBQ30436728-16C44E69-5A3B-4CF2-BB0C-66292E63A3D1Q33616561-2F6215BB-3D29-47FC-AB7D-A99ABE47A12BQ33694502-D041C64A-C61C-40D1-8238-2B7700440687Q33830572-D8580E7D-0569-44E9-817C-84DC17F10104Q33967781-4F9F1E13-6CFB-4FA4-845C-52BA196CEA7DQ34714815-BE8660D2-71F1-42B7-B6E7-4BB470B90466Q35002066-89B77D51-F51A-43A6-972F-01E2EF863CA1Q35750582-190F7ADC-1887-471D-AC4A-323859CA9BE4Q35995627-A79F9C60-3BE4-460C-BE3C-D6BF41C72D1DQ36020776-54E07BEF-0536-44D9-B546-EC9209ECC76BQ36121377-DC1F4971-648C-41DC-9329-655DD84A0249Q37237540-404B3F73-1D20-4BA3-89DD-85BD9BFD3AC7Q37737296-344E2796-6CEB-4EF0-B9C3-8AC1D6F96797Q37964897-F8A2AC54-B13F-4394-A904-72448F16C305Q37977251-EF5BFB25-3C7E-4C7E-9749-102C7336BA8BQ37986572-A8CA8C30-905E-4C01-88D9-EE3EEAC9A4A7Q39451637-7F3D68B3-B0B8-4511-BA99-B6BCC8BBA14DQ46913757-4EB773D0-FE6C-4B68-B662-A2EB92A53A0BQ47781525-9CCCED54-F886-4989-AF40-661B7C11B9A6Q48611292-E301ECA7-1621-458A-8357-F0FC4C6DDC95Q48831624-D908AC57-1BD9-4BFC-816F-EFC96DD087D8Q50636887-817FC820-FF4C-43D5-AAE2-37F9DCB160F0
P2860
Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@en
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@nl
type
label
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@en
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@nl
prefLabel
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@en
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@nl
P2093
P1433
P1476
Pathologic and nicotinic recep ...... mer disease, and normal aging.
@en
P2093
Donald J Connor
Flora Shah
Lars Kristofer N Peterson
Marwan N Sabbagh
Richard T Reid
P304
P356
10.1001/ARCHNEUR.63.12.1771
P577
2006-12-01T00:00:00Z